Literature DB >> 32327151

Homeostatic and pathogenic roles of PI3Kδ in the human immune system.

Georgios Sogkas1, Ignatius Ryan Adriawan2, Natalia Dubrowinskaja2, Faranaz Atschekzei2, Reinhold Ernst Schmidt2.   

Abstract

Phosphoinositide 3-kinase delta (PI3Kδ) mediates signaling transduction downstream of diverse immune receptors, including the T cell receptor (TCR), the B cell receptor (BCR), costimulatory molecules and cytokine receptors. Our understanding of the role of PI3Kδ in the immune system comes primarily from mice, and especially from the consequences of pharmacological inhibition of PI3Kδ in mouse models of human disease as well as the consequences of genetic manipulation, resulting in hyperactivation or loss of PI3Kδ function. In case of humans, in vitro studies with PI3Kδ-specific inhibitors, the consequences of treatment of hematologic malignancies with the PI3Kδ-specific inhibitor idelalisib and primary immunodeficiency disorders due to germline variants hyper- or underactivating PI3Kδ provide most of our knowledge on the role of PI3Kδ in immunity and immune regulation. In this review, we summarize the physiological and pathophysiological roles of PI3Kδ in the human immune system, focusing on immunodeficiency due to defects in PI3Kδ signaling and especially on the recently reported cases with mutations resulting in loss of PI3Kδ activity.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APDS; CVID; Idelalisib; Leniolisib; PASLI; PI3Kδ; PI3Kδ inhibitors; PI3Kδ loss-of-function; PIK3CD; PIK3R1; Primary immunodeficiency; p110δ; p85α

Mesh:

Substances:

Year:  2020        PMID: 32327151     DOI: 10.1016/bs.ai.2020.02.001

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  5 in total

1.  Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency.

Authors:  Georgios Sogkas; Natalia Dubrowinskaja; Katharina Schütz; Lars Steinbrück; Jasper Götting; Nicolaus Schwerk; Ulrich Baumann; Bodo Grimbacher; Torsten Witte; Reinhold E Schmidt; Faranaz Atschekzei
Journal:  Int Arch Allergy Immunol       Date:  2021-10-07       Impact factor: 2.749

2.  Identification of transcription factors and construction of a novel miRNA regulatory network in primary osteoarthritis by integrated analysis.

Authors:  Ying Jiang; Yi Shen; Shengli Xia; Liying Jiang; Liyan Ding
Journal:  BMC Musculoskelet Disord       Date:  2021-12-02       Impact factor: 2.362

3.  Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors.

Authors:  Luzia Bruns; Victoria Panagiota; Sandra von Hardenberg; Gunnar Schmidt; Ignatius Ryan Adriawan; Eleni Sogka; Stefanie Hirsch; Gerrit Ahrenstorf; Torsten Witte; Reinhold Ernst Schmidt; Faranaz Atschekzei; Georgios Sogkas
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

4.  Case Report: A Highly Variable Clinical and Immunological Presentation of IKAROS Deficiency in a Single Family.

Authors:  Taco W Kuijpers; Samantha A M Tromp; Ester M M van Leeuwen; Godelieve J de Bree
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 5.  Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.

Authors:  Georgios Sogkas; Faranaz Atschekzei; Ignatius Ryan Adriawan; Natalia Dubrowinskaja; Torsten Witte; Reinhold Ernst Schmidt
Journal:  Cell Mol Immunol       Date:  2021-04-01       Impact factor: 11.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.